NCT02958475 (MMM) is a NA clinical trial of Social Support Group (Facebook) in Breastfeeding, sponsored by University of Colorado, Denver.

Who is sponsoring NCT02958475?

NCT02958475 is sponsored by University of Colorado, Denver.

What drugs are being tested in NCT02958475?

Interventions in NCT02958475: Social Support Group (Facebook), Breastfeeding messages, Injury Prevention Messages.

What condition does NCT02958475 study?

NCT02958475 studies Breastfeeding.

Is NCT02958475 still recruiting?

NCT02958475 is currently completed. Last updated 26 February 2021.

Last reviewed 2021-02-26 · How we verify

NCT02958475: MMM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mother's Milk Messaging: Evaluation of a Bilingual Application (APP) to Support Initiation and Exclusive Breastfeeding in New Mothers

Completed NA Last updated 26 February 2021

What this trial tests

NA trial testing Social Support Group (Facebook) in Breastfeeding in 346 participants. Completed in 31 July 2020.

Timeline

25 September 2017

Primary endpoint
31 July 2020

31 July 2020

Quick facts

Lead sponsor	University of Colorado, Denver
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	346
Start date	25 September 2017
Primary completion	31 July 2020
Estimated completion	31 July 2020
Sites	1 location across United States

Drugs / interventions tested

Social Support Group (Facebook)
Breastfeeding messages
Injury Prevention Messages

Conditions studied

Breastfeeding — all drugs for Breastfeeding →

Sponsor

University of Colorado, Denver

Who can join

Adults 18 to 40, female only, with Breastfeeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is being conducted to evaluate the breastfeeding support program utilizing bilingual English-Spanish tailored text messages and online support to support exclusive and continuous breastfeeding for new mothers--comparing texting alone, texting with an online support group to those with usual care. The cost involved in moderating the online groups and providing bidirectional consultation when needed will be evaluated and qualitative feedback from a subset of mothers in both intervention groups will be evaluated to determine what was effective, as well as suggestions for improvement of the messaging program.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mother's Milk Messaging™: trial evaluation of app and texting for breastfeeding support.
Bunik M, Jimenez-Zambrano A, Solano M, Beaty BL, et al · · 2022 · cited 7× · PMID 36002798 · DOI 10.1186/s12884-022-04976-6

Verify or expand the search:

Other recruiting trials for Breastfeeding

Currently open trials in the same condition.

NCT07413185 — Relationship Between the Severity of Sleep Deprivation in the First 48 Hours Postpartum, Breastfeeding Motivation, and B · recruiting
NCT07293559 — Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States · recruiting
NCT05377372 — Early Life Exposures Among Children With Sickle Cell Disease · NA · recruiting
NCT07341256 — Father-Focused Breastfeeding Education and Breastfeeding Outcomes · NA · recruiting
NCT07499466 — Peer-Support Breastfeeding Program for Mothers in Severe Socioeconomic Deprivation: Feasibility Study · recruiting

Other University of Colorado, Denver trials

Trials by the same sponsor.

NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02958475 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
Last refreshed: 26 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02958475.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing